Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
(85 g) provides 93% of the DV (22,27)
Since that early description, it has drawn steady interest in the scientific literature, largely because preclinical work has reported a wide-ranging pattern of regenerative activity
Most non-surgical skin tightening treatments have little to no downtime
These medications may reduce how long B12 remains in the body, requiring individuals to supplement more frequently to maintain appropriate levels